Company | Name | Exchange | Sector | Industry | Market Cap | P/E Ratio | PEG Ratio | Last Trade Price | Day Change (%) | Fair Value | Fair Value Upside | Fair Value Label | Analyst Price Target | Analyst Target Upside | Overall Health |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
PharmaEssentia | Taiwan | Healthcare | Biotechnology & Medical Research | NT$204.15B | 47.2x | 0.23 | NT$559 | 8.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 18.5% Upside | Upgrade to Pro+ | |
Lumosa Therapeutics | TPEX | Healthcare | Biotechnology & Medical Research | NT$48.60B | -75.9x | 0.65 | NT$296 | 2.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 24.8% Upside | Upgrade to Pro+ | |
Polaris Group | Taiwan | Healthcare | Biotechnology & Medical Research | NT$28.39B | -9.1x | 0.17 | NT$36.90 | 0.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Sunmax BioTech | TPEX | Healthcare | Biotechnology & Medical Research | NT$22.87B | 32.7x | -17.94 | NT$411.50 | -2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
TaiMed Biologics | TPEX | Healthcare | Biotechnology & Medical Research | NT$20.68B | -84.9x | 0.79 | NT$75.50 | -0.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Foresee Pharmas | TPEX | Healthcare | Biotechnology & Medical Research | NT$12.73B | -8.5x | 0.17 | NT$82.80 | 0.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Tanvex BioPharma | Taiwan | Healthcare | Biotechnology & Medical Research | NT$12.34B | -7.3x | -0.2 | NT$52.90 | 2.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Gongwin Biopharm | TPEX | Healthcare | Biotechnology & Medical Research | NT$12.32B | -200.2x | -4.44 | NT$101.50 | 1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
PharmaEngine | TPEX | Healthcare | Biotechnology & Medical Research | NT$9.63B | 5.9x | 0.02 | NT$67.70 | 1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Mycenax Biotech | TPEX | Healthcare | Biotechnology & Medical Research | NT$7.86B | -15.7x | -5.08 | NT$37.55 | -1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
OBI Pharma | TPEX | Healthcare | Biotechnology & Medical Research | NT$6.88B | -2.7x | 1.14 | NT$26.55 | 1.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Twi BioTech | TPEX | Healthcare | Biotechnology & Medical Research | NT$4.22B | -22.2x | -0.73 | NT$36.50 | -7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Bionet | TPEX | Healthcare | Biotechnology & Medical Research | NT$4.22B | 56.7x | 4.54 | NT$78.70 | -0.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Medigen BioTech | TPEX | Healthcare | Biotechnology & Medical Research | NT$4.04B | -52.8x | -0.64 | NT$29 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Senhwa Biosciences | TPEX | Healthcare | Biotechnology & Medical Research | NT$3.66B | -13.1x | -2.92 | NT$41.05 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
SINEW Pharma | TPEX | Healthcare | Biotechnology & Medical Research | NT$3.40B | -23.9x | -1.15 | NT$48.15 | 0.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
TaiRx | TPEX | Healthcare | Biotechnology & Medical Research | NT$3.06B | -21.4x | -0.76 | NT$27.55 | -0.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
GlycoNex | TPEX | Healthcare | Biotechnology & Medical Research | NT$2.73B | -13.5x | -0.76 | NT$24.95 | -1.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Applied BioCode | Taiwan | Healthcare | Biotechnology & Medical Research | NT$2.43B | -9.5x | 0.43 | NT$23.30 | -1.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -5.6% Downside | Upgrade to Pro+ | |
Genomics BioSci &Tech | TPEX | Healthcare | Biotechnology & Medical Research | NT$1.96B | -11x | 0.85 | NT$27.55 | 2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Golden BioTech | TPEX | Healthcare | Biotechnology & Medical Research | NT$1.87B | -5.9x | -0.23 | NT$11.55 | 0.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Abnova | Taiwan | Healthcare | Biotechnology & Medical Research | NT$1.55B | -235.9x | 2.13 | NT$25.95 | 1.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Genesis Genetics Asia | TPEX | Healthcare | Biotechnology & Medical Research | NT$1.47B | 45.9x | -1.68 | NT$56 | 1.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Kim Forest Enterprise | Taiwan | Healthcare | Biotechnology & Medical Research | NT$1.43B | -8.1x | 3.82 | NT$23.10 | -1.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Dv Biomed | TPEX | Healthcare | Biotechnology & Medical Research | NT$1.40B | 28x | -1.26 | NT$58 | 0.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Taiwan Advance Bio-Pharma | TPEX | Healthcare | Biotechnology & Medical Research | NT$1.26B | 54.9x | 7.21 | NT$13.70 | -2.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Inalways | TPEX | Healthcare | Biotechnology & Medical Research | NT$1B | 95.9x | 0.45 | NT$20.30 | 0.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
SynCore BioTech | TPEX | Healthcare | Biotechnology & Medical Research | NT$989.88M | -18.8x | 0.08 | NT$27.25 | -3.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
BioLASCO Taiwan | TPEX | Healthcare | Biotechnology & Medical Research | NT$858M | 17.6x | 1.01 | NT$32.55 | -2.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Sofiva Genomics | TPEX | Healthcare | Biotechnology & Medical Research | NT$697.47M | -94x | 0.76 | NT$32.35 | 0.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
TaiwanJ Pharmas | TPEX | Healthcare | Biotechnology & Medical Research | NT$643.38M | -25x | -1.84 | NT$8.05 | 0.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Welgene Biotech | TPEX | Healthcare | Biotechnology & Medical Research | NT$522.02M | 225.9x | 1.84 | NT$22.40 | 0.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ |